Huntington disease (HD) is an autosomal dominant neurodegenerative disease with complete penetrance. Although the understanding of the cellular mechanisms that drive neurodegeneration in HD and account for the characteristic pattern of neuronal vulnerability is incomplete, defects in energy metabolism, particularly mitochondrial function, represent a common thread in studies of HD pathogenesis in humans and animal models. Here we review the clinical, biochemical, and molecular evidence of an energy deficit in HD and discuss the mechanisms underlying mitochondrial and related alterations.
Fanny Mochel, Ronald G. Haller
Title and authors | Publication | Year |
---|---|---|
New label-free methods for protein relative quantification applied to the investigation of an animal model of Huntington Disease
F Cozzolino, A Landolfi, I Iacobucci, V Monaco, M Caterino, S Celentano, C Zuccato, E Cattaneo, M Monti, DR Borchelt |
PloS one | 2020 |
Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases
D Chen, T Zhang, TH Lee |
Biomolecules | 2020 |
Impaired response of cerebral oxygen metabolism to visual stimulation in Huntington’s disease
P Klinkmueller, M Kronenbuerger, X Miao, J Bang, KE Ultz, A Paez, X Zhang, W Duan, RL Margolis, PC van Zijl, CA Ross, J Hua |
Journal of Cerebral Blood Flow & Metabolism | 2020 |
Developmental Trajectory of Height, Weight, and BMI in Children and Adolescents at Risk for Huntington’s Disease: Effect of mHTT on Growth
A Tereshchenko, E van der Plas, KD Mathews, E Epping, AL Conrad, DR Langbehn, P Nopoulos |
Journal of Huntington's disease | 2020 |